Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002031964-24-000001
Filing Date
2024-08-02
Accepted
2024-08-02 15:19:34
Documents
1
Effectiveness Date
2024-08-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5642
  Complete submission text file 0002031964-24-000001.txt   6772
Mailing Address 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO CA 94129 415-865-2050
NILO Therapeutics, Inc. (Filer) CIK: 0002031964 (see all company filings)

EIN.: 992175125 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-520504 | Film No.: 241170526